Home » Multimedia » Podcasts » BioWorld Insider Podcast

BioWorld Insider Podcast

One-on-one with medical innovators

Breakthrough medicines, billion-dollar deals, spectacular clinical successes and crushing failures all play a part in biopharma’s dynamic story. Developers make scientific advancements with the potential to change everything, only to face regulatory conundrums and ever-fluctuating markets. BioWorld tracks key events in the fast-moving sector every business day. Now, the BioWorld Insider podcast lets you hear directly from the movers and shakers whose collective work is changing how we all live. Join us for a new conversation.

Subscribe to this Podcast

Rethinking obesity: Fitness may be more directly linked to health than weight
You Must Login to Listen
Duration: 21:20
01-30-2023
BioWorld Science Managing Editor Anette Breindl discusses her new analysis of multiple studies related to weight loss, metabolic health and fitness that in many ways go against mainstream theories about obesity.

Download transcript
Download episode
Looking ahead to 2023: CEOs contemplate the new normal
Play

Listen

Duration: 24:51
12-05-2022
Guests Karen Zaderej, CEO of Axogen Inc., Sean Bohen, CEO of Olema Oncology Inc., Rob Ross, the CEO of Surface Oncology Inc., and Rob Etherington, the CEO of Clene Nanomedicine Inc., speak about adapting their companies to the market’s new realities.

Download transcript
Download episode
Psychedelic evolution: Mindset Pharma looks to change mental health treatment
Play

Listen

Duration: 25:44
09-21-2022
James Lanthier, the CEO of Mindset Pharma Inc., talks about developing next-generation psychedelic medicines to treat neurological and psychiatric disorders.

Download transcript
Download episode
$1B+ biopharma deals keep values afloat, even amid muted volume
Play

Listen

Duration: 28:16
09-08-2022
BioWorld Senior Analyst Karen Carey chats about the collision of a volatile economic climate and big biopharma deals.

Download transcript
Download episode
Extending the human lifespan
Play

Listen

Duration: 41:38
07-17-2022
Extending the Human Lifespan, a BioWorld special report, examines the companies developing “Fountain of Youth” drugs. In this episode, the writers discuss this scientific holy grail.

Download transcript
Download episode
New therapies vie to change the fatal course of amyotrophic lateral sclerosis
Play

Listen

Duration: 33:04
06-03-2022
Executives from Amylyx Pharmaceuticals Inc. and Clene Inc., along with a key Penn State ALS expert, discuss what the future of medicine holds for patients.

Download transcript
Download episode
Biopharma’s correction? 2022 1Q investments are both up and down
Play

Listen

Duration: 17:38
05-02-2022
BioWorld Senior Analyst Karen Carey explores the newest data and where it is leading.

Download transcript
Download episode

Previous 1 2 3 4 5 Next

More Multimedia